
Stephan Schulze
Chief Financial Officer
Stephan Schulze joined Adjuvance Technologies as its Chief Financial Officer in 2019. From 2017-2019
Mr. Schulze served as the CFO of Ceva US Holdings, Inc. In 2014 he joined Continental Disc Corporation
as its CFO. Between 2007 and 2014 he worked for different affiliates of Boehringer Ingelheim as Director
of Finance, initially as Director Marketing & Sales Controlling and finally as Director of Operations
Controlling. During that time he was in charge of the financial integration of the acquired Fort Dodge
Animal Health business. Mr. Schulze worked at Eli Lilly and Company in various finance roles and
locations between 1999 – 2007. He started his career in finance working for Mercedes-Benz in 1994. His
educational background includes a Diplom-Betriebswirt (BA) from Verwaltungs-und
Wirtschaftsakademie, Stuttgart, and a Master of Business Administration from Vanderbilt University.